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Target-controlled infusion of propofol in 
dogs – evaluation of four targets for 
induction of anaesthesia 
G. C. Musk, D. S. J. Pang, T. Beths, D. A. Flaherty 
Four groups of 20 dogs were anaesthetised by means of target-controlled infusions of propofol designed to 
achieve 2·5 µg/ml, 3·0 µg/ml, 3·5 µg/ml or 4·0 µg/ml of propofol in blood. The dogs’ pulse rate and 
respiratory rate were recorded before premedication and induction, immediately after endotracheal 
intubation and three and five minutes later (times 0, 3 and 5, respectively), and their arterial blood pressure 
was recorded oscillometrically just before induction and at times 0, 3 and 5. The targets of 2·5, 3·0, 3·5 and 
4·0 µg/ml resulted in the successful induction of anaesthesia in 13 (65 per cent), 16 (80 per cent), 20 (100 
per cent) and 20 (100 per cent) of the dogs, respectively. The incidence of postinduction apnoea was 0 (0 per 
cent), one (5 per cent), two (10 per cent) and eight (40 per cent) at time 5 for groups 2·5, 3·0, 3·5 and 4·0 
µg/ml, respectively, and its incidence at time 5 was significantly higher in the 4·0 µg/ml group (P<0·05) than 
in the other groups. In all the groups there was a significant (P<0·05) decrease in blood pressure between 
just before induction and the later measurements. Although there were no statistically significant 
differences between the groups in terms of inducing anaesthesia at a specific target, a target of 3·5 µg/ml 
appears to ensure a successful induction of anaesthesia without a significant increase in the incidence of 
apnoea. 
TOTAL intravenous anaesthesia (TIVA) is widely used in 
human medicine, but is used much less in veterinary medi­
cine, where inhalational techniques are still most commonly 
applied for the maintenance of anaesthesia (Reid and Nolan 
1999). This is unfortunate, because TIVA has several potential 
advantages over the use of gaseous agents. For example, peo­
ple have been shown to recover significantly more quickly 
after being anaesthetised with a propofol-based TIVA tech­
nique, than after having anaesthesia maintained with a 
volatile agent (Vallane 1992, Biro and others 1995). Moreover, 
both the quality and controllability of propofol TIVA have 
been reported to be superior to inhalational anaesthesia 
(Miller 1994). Another important advantage is the elimina­
tion of the occupational exposure of operating theatre per­
sonnel to inhalational agents (Engbers 1996, Smith and White 
1998a). 
A variety of drug administration protocols can be used to 
achieve TIVA. The intermittent bolus administration of a drug 
may result in high peak plasma concentrations, and excessive 
depth of anaesthesia and side effects, alternating with troughs 
associated with inadequate anaesthesia and the possibility of 
awareness (Smith and White 1998b). Better control and a 
more steady state can be achieved by administering short-
acting drugs by continuous infusion, at either a variable or a 
constant rate. In the former case, the regimen involves the 
delivery of a bolus dose or a loading infusion to achieve an 
adequate blood concentration of drug for endotracheal intu­
bation, followed by a decreasing rate of infusion to compen­
sate for the redistribution and elimination of the drug, while 
maintaining an effective concentration at the drug’s site of 
action. This procedure requires an estimate of the rate of 
clearance of the drug, and the plasma concentration achieved 
may be higher or lower than the intended concentration. A 
commonly used ‘step-down’ procedure for the use of propo­
fol in human beings is to inject a bolus dose of 1 mg/kg, fol­
lowed by an infusion, initially at a rate of 10 mg/kg/hour for 
10 minutes, then 8 mg/kg/hour for the next 10 minutes, and 
finally a maintenance infusion rate of 6 mg/kg/hour; this is 
known as the ‘Bristol technique’ (Tackley and others 1987). 
In combination with nitrous oxide and fentanyl this tech­
nique achieves, on average, a plasma concentration of propo­
fol of 3 µg/ml (Aitkenhead 2001). In the case of a constant rate 
of infusion there is the potential, depending on the duration 
of anaesthesia and the drug’s pharmacokinetics, for the drug 
to accumulate and for its plasma concentration to exceed the 
intended or required level. Either a continuous or a variable 
rate of infusion can produce a more stable level of anaesthe­
sia than the use of intermittent boluses, and is more eco­
nomical in terms of the total amount of drug used (Fragen 
1991). 
A target-controlled infusion (TCI) of anaesthetic is 
designed to achieve a predicted target blood concentration 
based on population pharmacokinetics, and although the 
actual concentrations may be higher or lower than the target 
selected, it is likely to provide the closest approximation for 
an individual patient. For successful induction of anaesthe­
sia, the concentration of drug at the effector site in the brain 
must be sufficient to produce loss of consciousness. However, 
time is needed to transfer the drug from the blood to the 
effector site, and this time depends on the concentration gra­
dient between the blood and the site; the steeper the gradient, 
the shorter the time required to induce anaesthesia. A high 
target blood concentration will result in the rapid induction 
of anaesthesia, but may be accompanied by an unacceptable 
degree of cardiopulmonary depression due to the high blood 
concentration of the drug, whereas a lower target blood con­
centration may minimise these effects, but unacceptably pro­
long the time to induce anaesthesia. The aim, therefore, is to 
achieve a balance between the successful induction of anaes­
thesia within an acceptable period, and the avoidance of 
cardiovascular and respiratory depression. 
The technique involves the computer-controlled admin­
istration of the drug by means of an infusion pump. The 
pharmacokinetic profile of the drug is programmed into the 
computer and the rate of infusion is determined by the rate 
of redistribution and elimination of the drug from the body. 
The pharmacokinetic model determines the initial rate of 
infusion, in the form of a rapid zero-order infusion to achieve 
the predicted target concentration, and this is followed by a 
slower rate to maintain this concentration (Beths and others 
2001). The result will approximate a stable plasma concen­
tration of drug, which can easily be changed in response to its 
clinical effects (Smith and White 1998b). The disadvantages 
of the system are the potential variability between patients 
Veterinary Record (2005) 
157, 766-770 
G. C. Musk, BSc, BVMS, 
CertVA, MRCVS, 
D. S. J. Pang, BVSc, 
MRCVS, 
T. Beths, DVM, CertVA, 
MRCVS, 
D. A. Flaherty, BVMS,
 
DVA, DipECVA, MRCA,
 
MRCVS,
 
Division of Companion
 
Animal Sciences, Institute
 
of Comparative Medicine,
 
University of Glasgow
 
Veterinary School,
 
Bearsden Road, Bearsden,
 
Glasgow G61 1QH
 
Mr Pang’s present address 
is Departement 
d’Anesthésie, Faculté 
Médicine Vétérinaire, 
Université de Montréal, 
Québec, Canada 
The Veterinary Record, December 10, 2005   Downloaded from veterinaryrecord.bmj.com on January 4, 2011 - Published by group.bmj.com 
Papers & Articles 
TABLE 1: Mean (sd) ages and weights, and the numbers of different breeds constituting the 
four groups of 20 dogs with target blood concentrations of 2·5, 3·0, 3·5 and 4·0 µg/ml 
propofol 
Group 
2·5 µg/ml  3·0 µg/ml  3·5 µg/ml  4·0 µg/ml 
Age range (years)  0·8-7·5  0·5-7·0  0·6-8·0  0·5-8·0 
Mean (sd) age (years)  4·15 (2·46)  3·06 (2·13)  4·09 (2·78)  3·68 (2·84) 
Weight range (kg)  8·5-56·0  4·0-68·0  3·5-71·5  7·8-54·5 
Mean (sd) weight (kg)  30·91 (45·6)  22·0 (14·4)  29·6 (17·5)  29·1 (14·3) 
Number of different breeds  14  14  15  14 
and the expense of both the anaesthetic drug and the infusion 
pump (Smith and White 1998b). 
The pharmacokinetics of propofol (a rapid distribution 
phase, rapid elimination and lack of accumulation on 
repeated administration) make it suitable for use either as an 
intravenous anaesthetic alone or for the induction of anaes­
thesia (Lumb and Jones 1996). These properties give it an 
advantage over other intravenous induction agents and make 
it the most suitable drug for the maintenance of anaesthesia 
by continuous infusion (Reid and Nolan 1999). The mean 
induction doses of propofol given by slow intravenous injec­
tion in unpremedicated and premedicated dogs have been 
reported to be 6·55 mg/kg and 4·5 mg/kg, respectively 
(Morgan and Legge 1989). These doses approximate to pre­
dicted peak concentrations of 8·4 µg/ml and 5·8 µg/ml propo­
fol in the blood, according to a modelling program for 
intravenous drugs (PK-SIM  version 3.11; Specialized Data 
Systems), considerably higher than the targets assessed here. 
A bolus induction dose may be associated with considerable 
cardiovascular and respiratory depression, and apnoea has 
been reported frequently. In dogs apnoea is reported to be the 
most prevalent adverse side effect after induction with propo­
fol (Smith and others 1993) and it appears to be independent 
of the preanaesthetic agent given. In human studies it has 
been demonstrated that there is less cardiorespiratory depres­
sion when anaesthesia is induced with propofol by means of 
a TCI system (Taylor and Kenny 1998), most probably because 
the drug is administered at a relatively slower rate and the 
induction dose is smaller. 
Propofol TCI is widely used in human anaesthesia, but it has 
only recently been reported in dogs (Beths and others 2001). 
Beths and others (2001) induced anaesthesia in 16 dogs and 
concluded that an induction target of 3 µg/ml consistently 
produced ideal conditions for intubation within three min­
utes, and, although slow, the induction of anaesthesia was 
remarkably smooth and controlled. The optimisation of an 
induction target was not the aim of their study, and although 
anaesthesia was induced at this target concentration in nine of 
16 dogs, the conclusion was based only upon a clinical impres­
sion. Targets of up to 15 µg/ml were investigated, but at the 
higher induction targets the incidence of muscle twitching and 
postinduction apnoea was unacceptably high, despite a rapid 
induction of anaesthesia. The choice of induction target will 
be influenced by several factors, including the premedicant 
drugs, the age, physical condition and health of the dog, and 
the speed at which it is desired to induce anaesthesia. 
In view of the many potential benefits of TCI and its rela­
tive ease of use, this study was undertaken to investigate the 
suitability of four different propofol target concentrations for 
the induction of anaesthesia in healthy dogs. The targets were 
chosen on the basis of the study by Beths and others (2001). 
MATERIALS AND METHODS 
The study was a prospective randomised study of 80 client-
owned dogs aged between six months and eight years and with 
TABLE 2: Numbers of dogs in each of the four groups of 20 
dogs with target blood concentrations of 2·5, 3·0, 3·5 and 4·0 
µg/ml propofol in which anaesthesia was not induced at the 
target concentration and the concentrations at which they were 
induced 
Group 
2·5 µg/ml 3·0 µg/ml 3·5 µg/ml 4·0 µg/ml 
Number of dogs in which 
anaesthesia was not 
induced at the 
designated target  7  4  0  0 
Target required (µg/ml) 
(number of dogs)  3·0 (5) 
3·5 (2) 
3·5 (2) 
4·0 (1) 
4·5 (1) 
American Society of Anesthesiologists scores 1 or 2, which 
underwent minor to moderate surgical procedures at the 
University of Glasgow veterinary school. The dogs were ran­
domly assigned using computer-generated numbers to four 
groups of 20. After a preanaesthetic clinical examination and 
a fasting period of 12 hours, the dogs were premedicated with 
a combination of 0·03 to 0·05 mg/kg acetylpromazine (ACP 
Injection; C-Vet), up to a maximum of 1 mg, and 0·2 mg/kg 
morphine (Morphine Sulphate Injection BP;  Martindale 
Pharmaceuticals) by intramuscular injection, 20 to 30 minutes 
before anaesthesia was induced. A cannula was placed in a 
cephalic vain and 100 per cent oxygen was administered via a 
face mask during the induction period. Propofol (Rapinovet; 
Schering Plough Animal Health) was administered through 
a TCI system programmed for propofol in dogs. The age and 
weight of the dog, and the concentration of propofol, were 
entered as the variable parameters and one of the four target 
blood concentrations was selected. Three minutes after the TCI 
display screen indicated that the target blood concentrations 
of propofol had been attained, endotracheal intubation was 
attempted; the conditions for intubation were considered ade­
quate if there was no swallowing or tongue withdrawal. A 
laryngoscope was not used and the anaesthetist was not 
blinded to the induction target. If the dog could not be intu­
bated the target concentration was increased by 0·5 µg/ml and 
by the same increment each minute thereafter until intubation 
was possible; intubation was attempted one minute after each 
new target concentration was attained. After it had been intu­
bated, the dog was placed in lateral recumbency and connected 
to a non-rebreathing anaesthetic system with 100 per cent oxy­
gen delivered at an appropriate fresh gas flow. 
Each dog’s pulse rate and respiratory rate were recorded 
before premedication and induction, immediately after it had 
been intubated (time 0) and three (time 3) and five (time 5) 
minutes later. The pulse rate was assessed by palpation of a 
peripheral pulse, and the respiratory rate by observing the 
movements of the thoracic wall or of the reservoir bag of the 
breathing system. For the purposes of this study, postinduc­
tion apnoea was defined as apnoea lasting for more than 15 
seconds, after endotracheal intubation. If apnoea occurred, 
positive manual pressure ventilation was applied at a rate of 
four breaths per minute. Arterial blood pressure was recorded 
oscillometrically (DINAMAP; Critikion) before induction, 
immediately after the dog had been intubated, and three and 
five minutes later, with an appropriately-sized cuff placed over 
the dorsal pedal artery. A single measurement was taken at 
each time point. After collection of the final data five minutes 
after intubation, the anaesthetic was continued according to 
requirements for the individual case. 
No blood samples were collected to compare the actual 
blood concentration of propofol with the predicted target of 
the TCI system, because the performance of the system had 
been validated by Beths and others (2001). 
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FIG 1: Proportions of the dogs (95 per cent confidence 
intervals) with target blood concentrations of propofol of 2·5,  0·6 
3·0, 3·5 and 4·0 µg/ml in which anaesthesia was induced at 
the target concentration  0·5 
0·4 
The results were analysed by calculating 95 per cent con­
fidence intervals for the proportions of the dogs in the four 
groups that were successfully anaesthetised at the assigned 
target, and that were apnoeic after induction. A Z test was 
used to compare the proportions. A general linear model, 
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with the dog as a random factor (Tukey multiple compari- 0 
son), was used to compare the changes in blood pressure and 
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FIG 2: Proportions of 
the dogs (95 per cent 
confidence intervals) 
with target blood 
concentrations of 2·5, 
3·0, 3·5 and 4·0 µg/ml 
propofol which 
were apnoeic 
(a) immediately after 
they were intubated, 
(b) three minutes later 
weighed between 3·5 and 71·5 kg. There were 34 different 
breeds, and labrador retrievers were the most common (n=10), 
with Cavalier King Charles spaniels the second most common 
(n=7) (Table 1). There were no significant differences between 
P
r
o
p
o
r
t
i
o
n
0·3 
0·2 
the four groups with respect to their weight and age.  0·1 
The targets of 2·5, 3·0, 3·5 and 4·0 µg/ml propofol resulted 
in the successful induction of anaesthesia in 13 (65 per cent),  0 
16 (80 per cent), 20 (100 per cent) and 20 (100 per cent) of 
the dogs respectively; the differences were not statistically sig­
nificant (Fig 1). The dogs that were not successfully induced 
at their assigned target were induced at a higher target (Table 
2). 
The incidence of postinduction apnoea was six (30 per 
cent), six (30 per cent), seven (35 per cent) and nine (45 per 
cent) at time 0, two (10 per cent), two (10 per cent), three (15 
per cent) and eight (40 per cent) at time 3 and 0, one (5 per 
cent), two (10 per cent) and eight (40 per cent) at time 5 for 
groups 2·5, 3·0, 3·5 and 4·0 µg/ml, respectively (Fig 2). At time 
3 the incidence of apnoea was significantly higher in the 
group with the 4·0 µg/ml target than in the groups with the 
2·5 and 3·0 µg/ml targets, and at time 5 the incidence in the 
group with the 4·0 µg/ml target was significantly higher than 
in all the other groups. 
In each group there was a significant decrease in arterial 
blood pressure between just before induction and time 3 and 
5 (Fig 3). In the 2·5 µg/ml group there were significant 
decreases in arterial blood pressure when comparing between 
just before induction with times 0, 3 and 5. In the 3·0 µg/ml 
group the same effect was seen when comparing just before 
induction with times 0, 3 and 5 and also when comparing 
time 0 with time 3 and time 5. For the 3·5 µg/ml group the 
same trends were evident when comparing just before induc­
tion with time 3 and time 5, and when comparing time 0 with 
time 5. In the 4·0 µg/ml group there was a significant decrease 
–0·1 
2·5  3·0  3·5  4·0  and (c) five minutes 
Target blood concentration (µg/ml)  later 
in arterial blood pressure when comparing just before induc­
tion with times 0, 3 and 5. The results show that when com­
paring preinduction values with measurements taken three 
and five minutes after induction there is a significant decrease 
in blood pressure in all groups. Although there was a signifi­
cant decrease in blood pressure in all the groups at times 3 and 
5, the incidence of hypotension (mean blood pressure <60 
mmHg) was relatively low (Table 3). A significantly higher 
proportion of the dogs in the 4·0 µg/ml group became 
hypotensive compared with the other three groups, but none 
of the dogs had a mean arterial blood pressure below 50 
mmHg. 
There was a significant drop in pulse rate in the 2·5 µg/ml 
group when comparing just before induction with time 5 (Fig 
4). In the 3·5 µg/ml group there was a slight increase when 
comparing pulse rate just before induction with time 0 and 
a significant decrease when comparing time 0 with time 3 and 
time 5. In the other two groups there were no significant 
changes in pulse rate and overall there was no apparent trend 
in change in pulse rate within the groups. 
Muscle twitching was observed after induction in six dogs, 
the signs ranging from minimal twitching of the muscles of 
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the forelimbs, neck and face to opisthotonos; two of the dogs 
were in the 2·5 µg/ml group, one each in the 3·0 and 3·5 µg/ml 
groups and two in the 4·0 µg/ml group. 
In each of the groups, it was apparent that some of the 
dogs could have been intubated less than three minutes after 
the target blood concentration of propofol had been reached. 
However, to maintain a standard procedure, they were main­
tained on 100 per cent oxygen delivered via a face mask for 
the complete three minutes. 
DISCUSSION 
In human beings, blood propofol concentrations ranging 
from 3 µg/ml to 15 µg/ml have been used to induce anaes­
thesia (Chaudhri and others 1992, Taylor and Kenny 1998, 
Short and Bufalari 1999), and it can be concluded that there 
is no single blood concentration that will be correct for all 
patients. The dose must be titrated to obtain the required clin­
ical effect and chosen on an individual basis. The choice of 
induction target will be influenced by the drugs used for pre-
medication, age, patient status and the speed at which it is 
desired to induce anaesthesia. The pharmacokinetic model 
for TCI calculates the rate of infusion on a set of species-spe­
cific pharmacokinetic variables for propofol. On the basis of 
the fact that in human beings the half-life for equilibration 
between blood and the drug’s site of action is approximately 
2·6 minutes (J. B. Glen, personal communication), three min­
utes were allowed from the attainment of the desired target 
blood concentration to the first attempt at intubation. 
Subsequent attempts at intubation were made one minute 
after the attainment of the next target concentration, to allow 
for a second equilibration phase. 
A variety of side effects have been reported with propofol 
(Smith and others 1993), but the only adverse effects observed 
TABLE 3: Numbers of dogs in each of the four groups of 20 
dogs with target concentrations of 2·5, 3·0, 3·5 and 4·0 µg/ml 
propofol that suffered hypotension (mean arterial blood 
pressure [MAP] <60 mmHg) overall, and just before induction, 
at intubation and three and five minutes after intubation 
Group 
2·5 µg/ml 3·0 µg/ml3·5 µg/ml4·0 µg/ml 
Total dogs MAP <60 mmHg  1  6  3  8 
Just before induction  0  0  1  1 
Intubation  0  1  0  4 
Three minutes  1  6  0  5 
Five minutes  0  3  2  4 
20 
0 
PM  PI  0 3 5 
Time (minutes) 
FIG 4: Mean (sd) pulse rates of the four groups of 20 dogs 
with target blood concentrations of 2·5, 3·0, 3·5 and 4·0 µg/ml 
propofol before premedication (PM), just before induction 
(PI), immediately after intubation (0), and three and five 
minutes later 
in the dogs in the present study were related to excitation and 
respiratory depression. Excitatory effects following the admin­
istration of propofol to dogs are well recognised (Davies 1991, 
Smith and others 1993). Signs of central nervous system 
excitement, including involuntary movements, muscle 
tremors, twitching and coughing, may occur at all stages of 
induction, maintenance and recovery. The manifestations are 
often mild and it can be concluded that anaesthesia with 
propofol is generally smooth and provides satisfactory con­
ditions for surgery. In this study, six of the 80 dogs (7·5 per 
cent) displayed mild twitching and opisthotonos, a proportion 
similar to that observed in other studies (Davies 1991, Smith 
and others 1993). The intravenous administration of a ben­
zodiazepine may attenuate any movements which impede 
positioning or surgery (Davies 1991). 
Respiratory depression is an important complication of 
propofol anaesthesia in people, cats and dogs (Smith and oth­
ers 1993), and is a result of the direct depression of the cen­
tral inspiratory drive and the ventilatory response to PaCO2. 
It has been the most commonly reported adverse effect of 
propofol in dogs (Morgan and Legge 1989, Smith and others 
1993, Quandt and others 1998). Although there were no sta­
tistically significant differences between the groups in terms of 
inducing anaesthesia at a specific target, the relative incidence 
of postinduction apnoea may influence the choice of induc­
tion target. The incidence of apnoea decreased with time in 
each group but was always greater with the higher target con­
centrations. Five minutes after the induction of anaesthesia, 
eight (40 per cent) of the dogs in the group with a target of 4·0 
µg/ml were still apnoeic, suggesting that the incidence of 
apnoea was dose dependent, in agreement with the findings in 
other studies (Muir and Gadawski 1998). The higher target 
concentrations of propofol induced anaesthesia more reliably 
and, provided that respiration is monitored closely and inter­
mittent positive pressure ventilation can be provided, postin­
duction apnoea need not be a serious problem. 
Mean arterial blood pressure values were obtained oscil­
lometrically, a reliable method for the measurement of sys­
temic arterial blood pressure in dogs (Hamlin and others 
1982, Sawyer and others 2004). In all the groups there was a 
statistically significant decrease in mean arterial pressure 
when comparing measurements taken just before induction 
with time 3 and time 5. There was no similar trend in respect 
to the dogs’ pulse rate. These findings are consistent with the 
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results of other studies in human beings and dogs (Claeys and 
others 1988, Chaudhri and others 1992, Nolan and Reid 1993, 
Smith and others 1993). Propofol can decrease arterial blood 
pressure by depressing sympathetic neural output centrally, 
resulting in decreased systemic vascular resistance (Claeys and 
others 1988). Claeys and others (1988) concluded that the 
major haemodynamic effect of propofol was to decrease arte­
rial blood pressure by reducing systemic vascular resistance, 
rather than by reducing stroke volume or cardiac output. The 
effects of propofol on the baroreceptor reflex show that it 
resets the reflex to allow slower heart rates, despite a decrease 
in arterial pressure. It does not affect the sensitivity of the 
baroreflex (Sebel and Lowdon 1989). 
When using a TCI system to induce anaesthesia in a dog, 
the target concentration must be titrated to achieve the 
required effect in that individual; the aim should be to titrate 
the delivery rate to achieve the desired clinical effect while 
minimising the side effects. The effects of propofol are closely 
related to its blood concentration (Short and Bufalari 1999), 
which can be easily altered by changing the target on the 
syringe driver. Although controlled ventilation may be nec­
essary and the dog’s blood pressure should be monitored, 
propofol TCI is a suitable technique for the induction of anaes­
thesia in healthy dogs. Although there were no significant dif­
ferences between the four groups of dogs in terms of inducing 
anaesthesia at a specific target concentration, a target of 3·5 
µg/ml appears to offer a greater likelihood of a successful 
induction of anaesthesia without a significant increase in the 
incidence of apnoea. 
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